Skip to Content

W 906 (Ranitidine 150 mg)

Pill imprint W 906 has been identified as Ranitidine hydrochloride 150 mg.

Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; duodenal ulcer; zollinger-ellison syndrome (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ranitidine hydrochloride 150 mg W 906
Ranitidine hydrochloride 150 mg W 906
Ranitidine hydrochloride
W 906
150 mg
11.00 mm
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Wockhardt USA
National Drug Code (NDC):
Inactive Ingredients:
microcrystalline cellulose
croscarmellose sodium
magnesium silicate
silicon dioxide colloidal
magnesium stearate
castor oil
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63304-0838 Ranbaxy Pharmaceuticals Inc.
54569-4507 A-S Medication Solutions, LLC (repackager)
68115-0314 Dispensexpress Inc (repackager)
58016-0345 Southwood Pharmaceuticals Inc (repackager)
33261-0099 Aidarex Pharmacuticals, LLC (repackager)
53002-0552 Pharmedix (repackager)
67544-0483 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.